Oxford BioDynamics receives Frost & Sullivan Technology Innovation Award, 2015

Oxford BioDynamics receives Frost & Sullivan Technology Innovation Award, 2015

Oxford BioDynamics received a Technology Innovation Award from the growth consultancy Frost & Sullivan, for its EpiSwitch™ platform technology. EpiSwitch™ combines analysis of clinical samples with a machine learning algorithm to discover and evaluate biomarkers for diagnosing and monitoring diseases and chronic conditions associated with aberrant gene expression. The technology is currently being used in a number of pathologies including oncology, immunology, metabolic disorders and neurodegenerative diseases.